In agreement with its tumor suppressor role, exogenous BRCA1 expression in breast cancer cells led to reductions in endogenous IGF1R protein and mRNA levels and a marked decrease in IGF1R promoter activity. The gene discussed is IGF1R; the disease is neoplasm.